Used in pharmaceutical research as a key intermediate in the synthesis of potent dopamine receptor ligands. Shows activity in modulating dopamine D1 and D2 receptors, making it relevant for developing treatments for neurological disorders such as Parkinson’s disease and schizophrenia. Its structure allows for high selectivity and binding affinity, useful in creating targeted therapies. Also employed in structure-activity relationship (SAR) studies to optimize potency and reduce off-target effects in central nervous system drugs.